Audrey’s Selected Meeting List for January 2009 (Rev. Jan. 9)

***************************************************** Institute of Management Consultants Northern California, Saturday Morning, Jan. 10, 2009

Workshop: “HEADS UP!  Let 2009 Be Your Best Year Yet!”Date and Time: Saturday, January 10, 7:30 am - 12:30 pmSchedule:7:30am - Registration and Breakfast7:45am - Workshops promptly begin               Each session is one hour, 15 minutes long, with breaks between12:15 - 12:30 Wrap-upLocation: Hilton Garden Inn, 1800 Powell Street, EmeryvilleDescription Registration/Breakfast starts at 7:15.  (continental breakfast will be served)

Workshops start promptly at 7:45Pricing:$49 for IMC members $59 for Affiliates$69 for all others

Please sign up early to get your choice!  Space is limited.Any questions, email imcinfo@imcnorcal.org

Most of us love our work! Its called working IN the business. Taking time out to work ON the business is something that often gets set aside.  All too often working "ON the business" takes a backseat to doing what we love best -- servicing our clients.  This workshop is an opportunity to work on the business and leave with an action plan in at least three areas.  You’ll have a new confidence with direction, strategies and action items for making 2009 a great year!  This will free up the nagging thoughts about what you haven't done for the business and will support the work that you love to do.  When you register, you will choose three different breakout sessions from the seven listed below.  Workshop size is limited, so get your registration in EARLY to assure your seat in the sessions of your choice. To see more detail and bios of Workshop Facilitators, go to IMC NorCal at http://www.imcnorcal.org/cm/Home.htm or register at http://www.brownpapertickets.com/event/507961.  Creating an Effective Business Development Strategy for 2009  -  Deborah Hornberger

  2.  Web 2.0 for Your Business  -  Brett LaDove 3.  Partnering at the C-Level:  How to be a valued client executive resource, not a recession victim - Al Peterson  4.  Failing to Plan is Planning to Fail  -  Jon Seidel   5.  How To Get Started in Consulting  -  Jeff Thompson 6.  Consultant Risk Management:  Protecting your assets and staying out of jail

- Charles Wilson7.  Money Management: Making Yourself as Successful as You Make Your Clients   -  Lorre Zuppan***************************************************** EPPIC Annual Conference, Sunday, Jan. 11, 2009

Conference Theme: A Passage to Innovation in the Life SciencesDate: Sunday, January 11, 2009, Location: Crowne Plaza-Cabana Hotel, 4290 El Camion Real, Palo Alto (650-857-0787)

Topic DescriptionThe theme of this conference is Innovation in the Life Sciences and will feature prominent speakers from India as well as the US. A diverse group of speakers will span the breadth of innovation, focusing not only on new technologies, but also showcasing novel business models, processes and design. Speakers will include entrepreneurs, CEO’s, scientists and investors.

***************************************************** UCSC Extension, Monday Evening, Jan. 12, 2009

Event: Free Program Overview for:• Biotechnology• Bioinformatics• Bioscience Business and MarketingLocation: Cupertino Classroom, UCSC Ext., 10420 Bubb Road, Cupertino, CA 95014 (408) 861-3700Date and Time: Monday, 6–8:30 pm, January 12.No fee, but enrollment required.16649-008 (use course-section number to enroll

Topic DescriptionAre you interested in learning about the Bioinformatics, Biotechnology, and Bioscience Business and Marketing certificate programs and careers in these burgeoningbioscience arenas?

This special free information session provides an opportunity to meet instructors and other students, learn about program prerequisites, course content and program requirements, and see how these programs can help you advance your current career or break into a new field.***************************************************** JP Morgan 27th Annual Healthcare Conference, January 12-15, 2009

This event is the premier conference of its kind, bringing together established industry leaders, emerging fast-growth companies, innovative technology creators and globally minded service providers. It’s listed here because it’s the only major banking investment meeting covering life science that takes place in the Bay Area. The conference takes place each day Monday – Thursday at the St. Francis Hotel on Union Square in San Francisco.

JP Morgan expects 300 companies, both public and private, to deliver presentations to more than 3,500 investors.  The format is 30 minute presentations followed by 30 minute Q&A sessions in a separate room.

It is very difficult to get entrance to the conference unless you are an investor with JP Morgan or have an invitation as a presenting company. Access to the webcast of the presentations is open to all—these occur at the same time as the meeting and are accessible for up to 2 months after the event. Many industry professionals meet the attendees in venues around the St. Francis during the week.

Take advantage of the Webcasts to hear selection of public companies presenting at the meeting. Webcasts:  http://metameetings.com/webcasts/jpmorgan/healthcare09/

PUBLIC companies that have elected to webcast their presentations will be available at the link above.PRIVATE company presentations will not be webcast.    Presentations will be archived and available for review up to 90 days after the conference unless otherwise specified by the company.

You will need to register to access. See the agenda to learn which companies are available for webcast access.

*****************************************************

Bio2Device Group, Tuesday Evening, Jan. 13, 2009

Topic: “Insights from the Cast of a Technology Company”Moderator and Panelists:

Basil Fthenakis (Moderator), Corporate Attorney and Partner at TIPSGroup

Don Ross, Author and Angel Investor at Sand Hill Angels and Life ScienceAngels

Herman White, Fund Manager and General Partner at CrossBridge Ventures John Musser, Ph.D., COO of Pharmagenesis and CEO of EcoPharm (a spinoff

of Pharmagenesis) Tony Zhang, Ph.D., CEO and Chairman of Formurex Ken Mitchell, CFO and Cofounder of Gene Oracle Brian Boyer, Ph.D., Patent Attorney and Partner at TIPS Group

Event Schedule:Date and Time: Tuesday Evening, Jan. 13, 20096:00 to 6:45 pm --Join us for a light dinner and networking6:45 pm to 8:15 --Meeting will begin with B2DG Business, followedimmediately by the Panel Discussion, & followed by open networking9:00 pm – Close of networking.Register here for the January 13 meeting with the Cast from a TechnologyCompany. http://www.acteva.com/booking.cfm?bevaid=173675

Topic DescriptionAll companies have a lifespan, and the length of the life of the companyvaries according to several factors. TIPS Group is pulling together apanel of characters from their network, each character serving adifferent role in the creating and sustaining of a company. Thecharacters include the early stage entrepreneur that came up with theidea for the company and actively pitches the venture to build a team,partners, investors, and deal flow; the investor that listens to 100s ofpitches each year to identify good investments; the seasoned, serialentrepreneur that has experienced several ups and downs in thedevelopment of multiple companies; and, the lawyers that help structurethe company, negotiate deals for the company, and serve to protect,grow, and build value in the company. This session has been designed tobe of interest to any professional that has participated in such anecosystem.

Panelists and Modertor BiosBasil Fthenakis, TIPS GroupTIPS Group is a full service, business and intellectual property lawfirm with offices in Palo Alto and Washington DC. Basil is a corporateattorney with 30 years of legal experience. He serves as corporate andlitigation counsel to emerging technology companies with an emphasis oncorporate finance, governance, competitive practices, intellectualproperty and commercial transactions. Basil also serves as a Directorof PHYlogy, Inc., which develops and markets advanced-technologycommunications equipment for the telecommunications industry.

Don Ross, Sand Hill Angels and Life ScienceSand Hill Angels and Life Science Angels invest in new technologies. Don has been active in life sciences for 25 years and co-founded a lifesciences publishing company that was acquired in 2000. He is a coauthorof two college-level textbooks, as well as an active investor thatassists startups with strategic planning and business plan development.

Herman White, CrossBridge VenturesCrossBridge is a private equity fund focusing on early to late stageinvestments in the U.S. and Asia. Herman served as Senior V.P. and TeamLeader at Silicon Valley Bank (SVB) and was V.P. of Bus. Dev. atSumitomo Bank. Herman's current take on operation matters and

valuation can be found athttp://www.emergingmanagerfocus.com/departments/operation/operation.php

John Musser, Ph.D., Pharmagenesis and EcoPharm (a spinoffof Pharmagenesis)Pharmagenesis and EcoPharm develop pharmaceuticals. John is anaccomplished medicinal chemist with over 25 years of experience leadingdrug development. John has served as the V.P. of Chemistry and aCorporate Officer at Glycomed; a Group Leader at USV PharmaceuticalCorporation, (currently Aventis); and, Director of Medicinal Chemistryat Wyeth. He has served on 3 Editorial Advisory Boards, has authoredover 70 publications, and is an inventor on over 97 US patents.

Tony Zhang, Ph.D., FormurexFormurex is a contract research organization specializing inpre-formulation, formulation, and advanced drug delivery. Tony is aninventor having at least 7 issued and 36 pending patents; and, principleinvestigator of several government-funded projects. He was VicePresident and co-founder of Epitomics, Inc., a successful biotechcompany in Burlingame, a senior research scientist at Bayer Corp, and aresearcher at Genentech.

Ken Mitchell, Gene OracleGene Oracle offers products and research services worldwide. Ken hasover 14 years of experience in biotech, was a founder of Tocore, andheld scientific and management positions at Energy Biosystems, Maxygenand Codexis. Ken successfully developed Gene Oracle's businessmodel, which includes a proprietary platform for both a profitableservice and a market leading gene synthesis design software package.

Brian Boyer, Ph.D., TIPS GroupTIPS Group is a law firm with offices in Palo Alto and Washington DC,offering support for companies ranging from the one-person startup tothe large public company. Brian is an intellectual property attorneycounseling in biotech, pharma, medical devices, chemistry, materials,and relevant information technologies. Brian assists his clients in thecreation of dealflow through organizations, such as the Bay Area StartupNetwork, US Angel Investors, FountainBlue, and the Bio2Device Group.

Directions: New venue at TIPS' Conference Center 1000 Elwell Court,Palo Alto. Exit 101 and head North on San Antonio Road. Turn left ontoEast Bayshore Road. The TIPS office is on the corner of East Bayshoreand Elwell. A large parking area is at the rear of the building (eitherturn right at the FEDEX box off of Bayshore, or turn right onto Elwelland then right into the first driveway). See map and photo of the siteat http://biodevicegroup.org/addl_directions.html

NO DAYTIME MEETINGREGISTRATION REQUIRED Must pre-register through Acteva or pay at a B2DG morning meeting See details at www.bio2devicegroup.orgCost: Cost for pizza or salad only. Register at website when postedSponsor and Hosted by: TIPS Group <http://www.tipsgroup.com/>Acteva REGISTRATION REQUIRED<http://www.acteva.com/booking.cfm?bevaid=173675>

***************************************************** Japanese University Network in Bay Area (JUNBA), Annual Symposium / Technology Exhibition, Tuesday, Jan. 13, 2009

Topic: Clean Technology including Biofuel / Biotech, Solar Energy, Hydrogen, Electric Cars, Environmental and Other Issues.Date and Time: Tuesday, January 13, 2009 Location: San Francisco Airport Marriott, 1800 Old Bayshore Highway, Burlingame, CA 94010Cost: This is a free / open to public event

Topic DescriptionThe exhibitors include 20 Japanese Universities, University of California (Cal, David, Santa Cruz, San Diego), LBNL plus 7 US companies including Tesla Motors, Cobalt Biofuels.The detail about this event, programs for the Symposium and Technical Presentations, and the floor plan for the exhibition booths can be downloaded fromSee website for details on time, etc. http://www.jspsusa-sf.org/junba/junba2009.html***************************************************** UCSC Extension in Silicon Valley, Wednesday Evening, Jan. 14, 2009 Event: Free Program Overview for:• Clinical Trials Certificate* Regulatory Affairs CertificateLocation: Cupertino Classroom, UCSC Ext., 10420 Bubb Road, Cupertino, CA 95014 (408) 861-3700Date and Time: Wednesday, 6–8:30 pm, January 14.No fee, but enrollment required.16650-008 (use course-section number to enrollwww.ucsc-extension.edu/biosciences Topic DescriptionAre you considering moving into a position in clinical research or regulatory affairs? If so, attend UCSC Extension's free Clinical Trial and Regulatory Affairs Program Overview and gather the information you need to make an informed decision. Learn about these in-demand professions and the bioscience industry. Meet instructors and program alumni, and find out about prerequisites, program philosophy, and course content. See how these programs can help you advance your current career or break into an exciting new field. *****************************************************

IEEE, Components, Packaging & Manufacturing Technology Society, Wednesday Evening, January 14, 2009

Topic: “Microscope on a Chip: A Highly Compact Lensless High-Resolution Optofluidic Microscope (OFM)”Speaker: Xiquan Cui, PhD candidate in Electrical Engineering, CaltechTime: Optional dinner sat 6:30; Presentation at 7:30 PMCost: $25 if reserved by Jan. 12; $30 after (no cost for presentation at 7:30 pm)Place: Biltmore Hotel, 2151 Laurelwood Rd (Fwy 101 at Montague Expressway), Santa ClaraRSVP: by email to Janis Karklins, karklins@ieee.orgWeb: www.cpmt.org/scv  /  www.cpmt.org/scv/meetings/cpmt0901.html

Topic Descripton Low-cost and high-resolution on-chip microscopes are vital for reducing cost and improving efficiency for modern biomedicine and bioscience. Despite the needs, the conventional microscope design has proven difficult to miniaturize. I will present our work on the first implementation and application of two high-resolution, lensless and fully on-chip microscopes based on the optofluidic microscopy (OFM) method. These systems abandon the conventional microscope design, which requires expensive lenses and large space to magnify images, and instead utilizes microfluidic flow to deliver specimens across array(s) of micron-size apertures defined on a metal-coated CMOS sensor to generate direct projection images. The first system utilizes a gravity-driven microfluidic flow for sample scanning and is suited for imaging elongate objects, such as Caenorhabditis elegans; and the second system employs an electrokinetic drive for flow control and is suited for imaging cells and other spherical/ellipsoidal objects. The optofluidic microscope design, readily fabricable with existing semiconductor and microfluidic technologies, offers low cost and highly compact imaging solutions. More functionalities, such as on-chip phase and fluorescence imaging, can also be readily adapted into OFM systems. We anticipate that OFM can significantly address a range of biomedical and bioscience needs as well as engender new microscope applications.

Speaker BioXiquan Cui is currently a PhD candidate in Electrical Engineering at Caltech. He obtained his B.E. and M.S. in Optical & Electrical Engineering from Zhejiang University, China in 2003, and obtained his M.S. of Physics from Portland State University in 2005. He was interested in many research areas, and worked on a variety of projects in electronics, optics, MEMS and nanotechnology. At present, he is working on developing innovative bio-imaging techniques at the Biophotonics group at Caltech.

***************************************************** Bio2Device Group, Tuesday Morning, Jan. 20, 2009

Topic: "Sarbanes Oxley Today: Corporate Goverance in Life Science Companies"Speaker: Scott M. Taylor, CPA, Partner, Burr, Pilger & Mayer LLP and Clark Keeler, Director of Burr, Pilger & Mayer LLP’s Internal Control and Risk Management Practice

Date and Time: Tuesday, Jan. 20, 2009, 8:30 – 10:30 amLocation: Room 510, 505 W. Olive, Sunnyvale, CA (end of one-story office building next to Sunnyvale Public Library)Cost: Free

Topic DescriptionThe Sarbanes-Oxley Act was a step toward providing greater protection for the public capital markets. The Act itself has changed and adapted over the last five years, and its effects can be seen already in the government and insurance and will undoubtedly influence new regulatory oversight arising from the current market challenges. BPM will focus discussion on the Act’s goals relating to corporate governance and risk management and how attention to those issues can improve the operations of Life Science Companies.  Speaker BiosScott Taylor, CPA, a partner in the Assurance Services practice and a co-leader of the Life Science group at Burr, Pilger & Mayer LLP has 24 years of public accounting and private industry experience. His experience includes investment, real estate, health care, technology, software, biotech, nonprofit, and financial service industries. He consults with public and private company management on a variety of accounting and tax services including financial statements, audits, implementation of accounting systems, internal control evaluations preparation of forecasts and budgets, litigation support, and business plan development. Mr. Taylor is a Certified Valuation Analyst with an MS in Taxation – Golden Gate University and BA in Business Economics – University of California, Santa Barbara.

Clark Keeler, Director of Burr, Pilger & Mayer LLP’s Internal Control and Risk Management Practice, is a financial executive with broad experience in leading both finance and operations teams. He has proven his leadership capabilities in directing complex projects in diverse industries and organizational environments. His expertise is focused on managing growth and mitigating organizational risk, while improving existing infrastructure, systems and internal controls. He is a skilled strategist with a long track record of successfully helping clients create new business opportunities while identifying and implementing cost controls and process improvements. Mr. Keeler has thirty years of experience related to change management experience in both business finance and operations covering start-ups, turnarounds, merger & acquisitions, divestitures, as well as systems and business development, redesign and integration. He has extensive experience in leasing, distribution, manufacturing, transportation, retail, technology, life science and restaurant industries.Mr. Keeler also has five years experience operating a private consulting practice focused on financial management, internal control compliance and improved risk management. He has also served as the Chief Financial Officer for three companies. Mr. Keeler’s practice emphasizes the integration of strong internal controls with process improvements, and the optimization of internal financial systems.**************************************************** BioScience Forum, Wednesday Evening, Jan. 21, 2009

Topic: “Next Generation Therapy for Diabetes”Speaker: Harold Van Wart, Ph.D., President & CEO, MetabolexDate and Time: Wednesday, Jan. 19, 2009; 6:00pm - 9:00pm

6:00 PM - networking 7:00 PM - dinner 8:00 PM - presentationLocation: The Clarion Hotel, 401 East Millbrae Avenue, MillbraeFull info and Registration at:http://biosf.org/

Typical Cost: $50 before 11PM, Monday, Jan. 19th$60 on-site$30 full-time students pre-registration$35 full-time students on-site Acteva fees are added to the above prices Check website for latest information

Topic DescriptionThe incidence of Type 2 diabetes has reached epidemic proportions worldwide causing significant morbidity and mortality. A range of therapies that target the underlying defects are available that attempt to control blood sugar, but all have limitations.  After reviewing some background on the disease and its current treatment options, a few of the most promising next generation therapies will be presented. 

Speaker BiographyDr. Van Wart currently serves as Metabolex, Inc.’s Chief Executive Officer, a member of the Board of Directors since January 2003, and President since April 2001. He served as chief operating officer from December 2002 to January 2003 and senior vice president, research and development from October 2000 to December 2002. From 1999 to 2000, Dr. Van Wart was vice president and therapy head for arthritis and fibrotic diseases at Roche Biosciences, a biopharmaceutical company. From 1992 to 1999, he was vice president and director of the institute of biochemistry and cell biology at Syntex Corporation, a biopharmaceutical company acquired by Roche Biosciences in 1994. From 1978 to 1992, Dr. Van Wart served on the faculty of Florida State University. Dr. Van Wart obtained his Ph.D. from Cornell University. He currently serves on the Emerging Companies and Health Section Governing Boards of the Biotechnology Industry Organization, as well as on its Board of Directors. He is also a Director of Conatus, Inc.

***************************************************** Engineering in Medicine and Biology Society (EMBS), Santa Clara Valley Chapter, Wednesday Evening, Jan. 21, 2009

Title: “SmartMOVE Technology: A New Disruptive Actuator Technology”Speaker: Marcus Rosenthal, Artificial Muscle, Inc.Date and Time: Wednesday, Jan. 21, An optional dinner with the speaker precedes each meeting, and you are invited.  No reservation is needed.  See new dinner location below.The formal presentation is 7:30 - 8:30 pm. Afterwards, you are invited to join in discussion and networking over refreshments.Location: Clark Center auditorium, Stanford University

NEW DINNER LOCATION:Optional Dinner, Nexus cafeteria in the Clark Center, 6:15 pm (no host, noreservations)

Topic DescriptionArtificial Muscle, Inc. (AMI) is pursuing the commercialization of its artificial muscle technology and SmartMOVET actuators through innovative designs and fabrication processes and by focusing on performance, reliability and manufacturability across a wide variety of applications. Scalable solutions developed by AMI include pumps, valves, linear motion controllers, and vibration actuators for haptics, fluid mixing, and other applications. Innovative device designs demonstrating the ability to meet the specifications of demanding applications and combining practical levels of power densities and actuation lifetimes will be discussed. Integrated electronic control modules allow the freedom to design actuators directly into new or existing product lines while effectively managing the transition from conventional technologies. Simple modular designs, coupled with low cost industrial materials and flexible automated manufacturing processes, provide a cost effective solution for products serving such diverse industries as consumer electronics and medical devices. Several case examples are presented to illustrate the commercial viability of SmartMOVE-based devices.

Speaker BiographyMarcus Rosenthal is a Co-Founder of Artificial Muscle, Inc. (AMI) was formed as a spin-off of SRI International in March 2004 in order to commercialize smartMOVE technology. At AMI, Marcus has contributed in a large number of areas including technology development, product line development, manufacturing process development, and materials development.  Marcus is currently the Program Manager for the smartTOUCH product line which is AMI's product for haptic feedback. Prior to working at AMI, Marcus was a Research Engineer at SRI International from 2001-2004. Marcus was part of the Active Transducer Program at SRI where smartMOVE technology was one of the key developments. Marcus Rosenthal graduated with a B.S. in Mechanical Engineering from UC Berkeley in 2002.*****************************************************

East Bay Association of Women in Science, Thursday Evening, January 22, 2009Event: “An Evening of Networking--Our most popular event: An entire Chapter meeting devoted to networking!”Date and Time: Thursday, Jan, 22, 20096:30 – 7:00 PM light dinner and networking

7:00 - 8:00 PM Program

Location: Novartis Inc*., 4560 Horton St, Emeryville, CA            

Suggested donations: $5 member/ $10 non-members

Event DescriptionA brief review of networking strategies and techniques will be followed immediately by games to fine tune our networking skills and make those ever-important job contacts! Our expert hosts will engage us in effective networking games that enable you to meet and

exchange information with many people in a very short time. You will meet people in an informal, friendly setting while collaborating to perfect your skills.So, invite your colleagues, (don't forget men are invited too) and print out those business cards! Come to polish up your 'introduction', exchange cards, share networking skills, make new friends, and find out who's doing what in Bay Area science.

*Novartis security procedures require check-in at the guard station on 53rd St at Chiron Way prior to parking. Meeting is held in building 4 (5300 Chiron Way), Room 104. Enter the doors nearest the big yellow stucco ball. Sign in with the security at the front desk.

Scientists, Non-scientists, Men and Women Are All Welcome! If you are not an AWIS member yet – please join us! ***************************************************** Café Scientifique, Thursday Evening, Jan. 22, 2009

Topic: “What Will it Take to Defeat Alzheimer’s Disease and Related Disorders”Speaker: Lennart Mucke, MD, Director, Gladstone Institute of Neurological Disease, Professor of Neurology & Neuroscience, UCSF

Date and Time: Thursday, January 22, 2009 from 6:00 - 7:30 p.m.

Location: SRI Menlo Park, Middlefield Road at Ringwood - Dining Room in the International Building

Entrances to Conference Center parking are next to the church on Ravenswood and at Ringwood and Middlefield.

Topic Description                          Join Dr. Lennart Mucke for a discussion of the historical approaches to developing therapies for Alzheimer’s, what leading edge research is uncovering, as well as reasons for optimism in our ability to treat Alzheimer’s and other devastating neurological diseases.Alzheimer’s is a progressive and fatal neurological disease with an immense and growing impact on society.  Alzheimer’s affects 4.6 million new patients annually and is the seventh leading cause of death in the US.  More than two-thirds of patients are cared for by family and friends, and this exacts an enormous toll in terms of emotional stress, work disruptions and time.  Due to our aging demographics, the prevalence of Alzheimer’s in the US is expected to triple by 2050 to 13.2 million.Alois Alzheimer identified the disease in 1906.  Over 100 years later, there are multiple treatments available, but their benefits are only modest.  Breakthroughs in new treatments and protective therapies are needed, but these require a better understanding of the disease process.  At the Gladstone Institute of Neurological Disease (GIND), Dr. Mucke developed transgenic models of Alzheimer’s and Parkinson’s disease which lead to the identification of molecular processes that cause or modulate the course of these diseases.  GIND continues to lead investigative efforts into pathogenic factors and pathways at the molecular, cellular, network and behavioral level.

Speaker Bio

Dr. Mucke did his thesis research in neurophysiology and neuroanatomy at the Max-Planck-Institute for Biophysical Chemistry.  He then trained in internal medicine at the Cleveland Clinic and in neurology at Mass General.  He did a postdoctoral fellowship in neuroimmunology and neurovirology at the Scripps Research Institute.  In 1996, Dr. Mucke was recruited by the Gladstone Institutes and the UCSF Department of Neurology to head a new program in molecular neurobiology in San Francisco.   The rapid progress made by this program resulted in the establishment of GIND, which Dr. Mucke has directed since its inauguration in 1998.

Café Scientifique events are open to all free of charge.  No reservations are necessary.  For more information please visit our web site: http://www.cafescisv.org/ . Check the web for information about future and past events, including photos.  Feel free to forward this announcement to interested friends and colleagues. Sign up here to receive announcements.

Sponsored by ROXRO PHARMA and SRI, Café Scientifique is a place where anyone can come to explore the latest ideas in science and technology and debate science issues outside a traditional academic context.  We meet monthly to discuss a variety of science topics.  Feel free to forward this message to anyone you think could be interested. 

Coffee, tea and biscotti will be complimentary, provided by SRI - Bring your own mug if you wish to avoid using disposable cups.***************************************************** FountainBlue's Life Science Entrepreneurs' Forum, Monday Evening, Jan. 26, 2009

Topic: “Life Science Angel Investor's Panel” Angel Panelists:

Stuart Eckmann, Keiretsu Forum and Life Science Angels (Bio and Device Committees)

Elaine Heron, Life Science Angels and LabCyte Anne DeGheest, MedStars Don Ross, Life Science Angels and Sand Hill Angels

Featured Recently-Funded Entrepreneurs: Mitchell Mutz, CSO, Amplyx Pharmaceuticals Another Entrepreneur to be confirmed

Date and Time: Monday, January 26 from 5:30 - 7:30 p.m. Location: Jones Day, 1755 Embarcadero Road in Palo Alto.Pre-register for $20-$30, by visiting http://www.acteva.com/booking.cfm?bevaid=162521 by noon on Friday, January 23. Topic DescriptionLife science angel investors are generally seasoned executives with deep strategic and operational experience in running successful life science businesses, from concept to clinical trials to regulatory approvals, manufacturing and distribution. They generally also have extensive experience within corporations in various roles, and continue to develop these partnerships as they support their portfolio companies. The life science angel investors we’ve recruited for this month’s panel have been seen a wide range of life science business models, and have their own thoughts and recommendations on how to be successful in these challenging times. Topics will include how early stage companies can:–       position themselves for successful partnerships and fundings,

–       strategically plan your business based on evolving market needs, –       tightly manage cash flow, and–       build strategic alliances with larger organizations, angels, research organizations, and other key stakeholdersInformation and Registration: NO SERVICE PROVIDERS PLEASE.

Pre-register for $20-$30, by visiting http://www.acteva.com/booking.cfm?bevaid=162521 by noon on Friday, January 23. A limited amount of on-site registration is available for $40 plus $4 in fees, on a first-come, first-served basis.

Additional information about our life science entrepreneurs' forum and notes from our previous meetings are available at http://www.SVLifeScience.com

You are cordially invited to join FountainBlue’s community online by visiting http://www.bigtent.com/hosted/fountainblue/invitation?hosted_key=7c64713f1bb5ca6734f2cbe8830e7f0a. Membership costs are $40 annually, and membership benefits are highlighted at http://www.fountainblue.biz/aboutus/membership.html.

*****************************************************

Bio2Device Group, Tuesday Morning, Jan. 27, 2009

Speaker: Nancy Madison, Compliance Express,Topic: "Risk Management for Medical Devices"Date and Time: Tuesday, Jan. 27, 2009, 8:30 – 10:30 amLocation: Room 510, 505 W. Olive, Sunnyvale, CA (end of one-story office building next to Sunnyvale Public Library)Cost: Free

Topic Description

Risk management is an essential part of regulatory compliance for medical device companies.  In spite of its ever increasing importance, it is not always easy to find the information needed to determine specific risk management requirements and how to fulfill those requirements throughout the entire product life cycle of a medical device.  This presentation will focus on how to develop a risk management strategy which incorporates appropriate risk management activities at each stage of the product life cycle.  Nancy will give an overview of US and Global risk management requirements, discuss the primary source documents to be consulted in developing a risk management strategy, and give practical advice on how to incorporate risk management activities into the critical phases of the product life cycle.

Speaker Bio

Nancy Madison is President and  founder of Compliance Express, a company which provides regulatory compliance products, services, and training for medical device companies.  Prior to founding Compliance Express,  Nancy was Chief Marketing Officer for Peak Process where she led the marketing, product specification, and application engineering development efforts for its quality management products. Prior to

joining Peak Process, Nancy’s career spanned 22 years in the high tech industry in a variety of engineering, applications engineering, marketing, consulting, and management positions at both industry leaders such as Hewlett-Packard and Mentor Graphics and successful startups such as Legato Systems and Valid Logic Systems.  Nancy received a B.A. from George Washington University, an M.A. from Harvard University, and an M.S.E.E. from the University of California, Berkeley.***************************************************** Palo Alto AWIS , Thursday Evening, Jan. 29, 2009

Topic:  January Chapter Meeting: “Explorations in Science”Speaker: Julie Yu, Ph.D., staff scientist at the Exploratorium Teacher Institute

Schedule7:00-7:30 pm Networking and light supper7:30-7:45 pm Announcements7:45-8:45 pm Program8:45-9:00 pm Discussion

Date and Time: Thursday, Jan. 29, 7:00 pm - 9:00 pm

Schedule7:00-7:30 pm Networking and light supper7:30-7:45 pm Announcements7:45-8:45 pm Program8:45-9:00 pm DiscussionLocation: Palo Alto Research Center (PARC) Directions to PARC. For details and to register, go to http://www.pa-awis.org/RSVP online http://www.acteva.com/go/pa-awis

Welcome!! You don’t need to be a member to attend.All scientists, students, and their friends are welcome. Men too!Members pay $4 and non-members pay $7 to offset the cost of food.

Topic DescriptionDo you remember what sparked your interest in science? Why you love it? Join us for anenergizing presentation by Dr. Julie Yu, staff scientist at the Exploratorium TeacherInstitute in San Francisco. Dr. Yu will tell us how she is spreading the love of science bycreating interactive explorations for museum visitors and helping teachers teach sciencethe way many of us learned to love it – by doing and experimenting with our own hands.Inspiring public interest and understanding in science through all avenues is especiallyimportant to combat the current anti-science rhetoric and poor funding for classrooms. So, re-discover the fun and share the excitement with us!

Speaker BioAfter receiving her B.S. in chemical engineering from Brown University, Dr. Yu taughtmiddle school math and science in East Palo Alto and then K-12 science at the Tech

Museum in San Jose. Teaching science reminded her of how much she liked learningscience, so she went back to school and earned a PhD in chemical engineering with aminor in molecular and cell biology from UC, Berkeley. With a NSF Discovery CorpsFellowship, she did a postdoc at the Exploratorium Teaching Institute and has stayed onas a staff scientist. Her extracurricular activities are focused on her favorite synthesis ofchemistry and biology - cooking and eating.

***************************************************** Deadline for discount on indepth Bioscience Product Marketing Course, Fee: $700 ($630 through Jan. 29)—Cupertino, CASee course description and outstanding lineup of guest lecturers and short presentation speakers listed below.*****************************************************

Bioscience Product Marketing, February 12 – March 26, UCSC Ext, Cupertino, CA

This product marketing and selling-focused course gives participants an in-depth look at product planning and research, marketing planning, and promotional execution as they are done in the bioscience industry. Topics include market research methodologies, information sources and applications relevant to product planning; the development of marketing strategy, product positioning and differentiated claims; and the creation of tactical marketing programs and activities to maximize revenue potential. Course activities include the creation of a team-developed preliminary marketing plan presented in Powerpoint on March 26th.The course is well suited for all levels of professionals in bioscience marketing research, product management, product sales, advertising, public relations, business development and licensing, as well as other related functions, such as regulatory, clinical and legal.

Lead Instructor:

Audrey Erbes, Ph.D., is a life-science business development and marketing consultant and a developer of customized executive education. With more than 25 years of managerial experience in marketing and business development in the biotech and pharmaceutical industry, she was Executive Vice President and cofounder of Kowa Research Institute, a biopharmaceutical licensing and investment subsidiary of Kowa Company Ltd., Japan and before that held management positions at Syntex Corp. in market research, product management, strategic marketing and planning, and business development in the U.S. and abroad.

Guest Lecturers:

Stanley Skrzypczak, M.B.A., Director, Managed Care Marketing, Genomic Health, has over 25 years of successful biotech and pharmaceutical sales and marketing experience, including product, managed care, clinical marketing and sales management. "Marketing in a Biotech/Genomics Environment- Preparing for the Launch."

Charles Versaggi, Ph.D., is president of Versaggi Biocommunications®, a strategic marketing consultancy for biotechnology, pharmaceutical and medical technology companies. "Building Value through Strategic Marketing Planning and Communications."

Steven Wong, B.A., is a senior consultant at Plan A, a strategic marketing consulting firm servicing biotechnology and pharmaceutical companies. At Plan A, he has directed numerous consulting engagements, including opportunity assessments, complex population modeling, and therapeutic area. "Market Research Information Resources."

Short Talks:

Debbie Donovan, Director, Patient Activation & Market Development at Intuitive Surgical, “E-Marketing”

Erik Haghjoo, Simon-Kucher “Role of Pricing and Reimbursement in Product Management Strategic Planning”

Tais Schmitt, Ph.D., Certificate Student, “Class Project”

Enrollment Information:1654-014 (use course-section number to enroll) Fee: $700 ($630 through Jan. 29)Location:10420 Bubb Road, Cupertino Dates: 6 meetings: Thursdays, 6-9:30pm, February 12-March 26 (no meeting Mar. 19)You can learn more at http://www.ucsc-extension.edu/ and register online as well.